The c-myc oncogene downregulates class I HLA expression in human melanoma. The major class I HLA antigens are encoded by three loci, A, B, and C, and we investigated whether these loci are suppressed equally by c-myc. In three melanoma cell lines with high c-myc expression, we analyzed mRNA, protein, and cell surface expression of the class I HLA antigens. Whereas the HLA-B locus expression was found to be strongly reduced, the HLA-A locus was expressed normally. Analysis of c-myc-transfected clones of two melanoma cell lines confirmed that c-myc preferentially suppresses the class I HLA-B locus. Immunohistochemical analysis of fresh melanoma lesions also showed that in the tumors the HLA-A loci are expressed normally, while on the majority of tumor cells no HLA-B antigen expression was found. This downregulation may have consequences for the recognition of malignant cells by tumor-infiltrating lymphocytes. Our results predict that HLA-B-restricted cytotoxic T cells will be unable to kill high c-myc-expressing melanoma cells.
Skip Nav Destination
Article navigation
1 September 1989
Article|
September 01 1989
Suppression of class I human histocompatibility leukocyte antigen by c-myc is locus specific.
R Versteeg,
R Versteeg
Department of Clinical Oncology, University Hospital Leiden, The Netherlands.
Search for other works by this author on:
K M Krüse-Wolters,
K M Krüse-Wolters
Department of Clinical Oncology, University Hospital Leiden, The Netherlands.
Search for other works by this author on:
A C Plomp,
A C Plomp
Department of Clinical Oncology, University Hospital Leiden, The Netherlands.
Search for other works by this author on:
A van Leeuwen,
A van Leeuwen
Department of Clinical Oncology, University Hospital Leiden, The Netherlands.
Search for other works by this author on:
N J Stam,
N J Stam
Department of Clinical Oncology, University Hospital Leiden, The Netherlands.
Search for other works by this author on:
H L Ploegh,
H L Ploegh
Department of Clinical Oncology, University Hospital Leiden, The Netherlands.
Search for other works by this author on:
D J Ruiter,
D J Ruiter
Department of Clinical Oncology, University Hospital Leiden, The Netherlands.
Search for other works by this author on:
P I Schrier
P I Schrier
Department of Clinical Oncology, University Hospital Leiden, The Netherlands.
Search for other works by this author on:
R Versteeg
Department of Clinical Oncology, University Hospital Leiden, The Netherlands.
K M Krüse-Wolters
Department of Clinical Oncology, University Hospital Leiden, The Netherlands.
A C Plomp
Department of Clinical Oncology, University Hospital Leiden, The Netherlands.
A van Leeuwen
Department of Clinical Oncology, University Hospital Leiden, The Netherlands.
N J Stam
Department of Clinical Oncology, University Hospital Leiden, The Netherlands.
H L Ploegh
Department of Clinical Oncology, University Hospital Leiden, The Netherlands.
D J Ruiter
Department of Clinical Oncology, University Hospital Leiden, The Netherlands.
P I Schrier
Department of Clinical Oncology, University Hospital Leiden, The Netherlands.
Online ISSN: 1540-9538
Print ISSN: 0022-1007
J Exp Med (1989) 170 (3): 621–635.
Citation
R Versteeg, K M Krüse-Wolters, A C Plomp, A van Leeuwen, N J Stam, H L Ploegh, D J Ruiter, P I Schrier; Suppression of class I human histocompatibility leukocyte antigen by c-myc is locus specific.. J Exp Med 1 September 1989; 170 (3): 621–635. doi: https://doi.org/10.1084/jem.170.3.621
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement